Carregant...

Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513

BACKGROUND: Evaluate the anti-tumor activity of ozonide antimalarials using a chemoresistant neuroblastoma cell line, BE (2)-c. METHODS: The activity of 12 ozonides, artemisinin, and two semisynthetic artemisinins were tested for activity against two neuroblastoma cell-lines (BE (2)-c and IMR-32) an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Coulter, Don W., McGuire, Timothy R., Sharp, John G., McIntyre, Erin M., Dong, Yuxiang, Wang, Xiaofang, Gray, Shawn, Alexander, Gracey R., Chatuverdi, Nagendra K., Joshi, Shantaram S., Chen, Xiaoyu, Vennerstrom, Jonathan L.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5100253/
https://ncbi.nlm.nih.gov/pubmed/27821095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2872-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!